$RKLB

Not SpaceX. Not Blue Origin. The Space Titan That Morgan Stanley Calls an Undervalued Launch Play.

Morgan Stanley highlights Rocket Lab (RKLB) as an undervalued space stock with a $105 price target. The company has a $2.36B backlog and signed a 20-mission contract. It's expanding into space services via Iridium acquisition. RKLB trades at $75, with $769M revenue and a P/S ratio of 50, but is not profitable.

Original reporting
Published Oct 8, 2026, 11:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 11:28 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Not SpaceX. Not Blue Origin. The Space Titan That Morgan Stanley Calls an Undervalued Launch Play. — source image
Decision brief

The 30-second read

$RKLBBullishMed
01

Why it matters

The 20‑mission deal and Iridium acquisition provide a clear growth runway, potentially lifting the stock.

02

Market read

New contract and acquisition could re‑price Rocket Lab’s growth prospects in the space sector.

03

What to watch

Execution risk on the Neutron rocket and integration of Iridium may delay benefits.

Relevance 7/10Novelty 7/10Timing: today

Background

Rocket Lab is positioning itself as a broader space‑services provider beyond its Electron launch vehicle.

Company-level read

Ticker impact

$RKLBBullishHigh confidence
Context

Rocket Lab signed a 20‑mission contract with Synspective worth $2.36 billion and is finalising its acquisition of Iridium Communications.

Expected impact

likely upside as investors price in higher future launch and satellite service revenue

Evidence & confidence

Contract size and acquisition are material new facts that can boost growth expectations.

Market effects

strengthens the commercial launch segment and may pressure peers like SpaceX and Blue Origin.

U.S. space‑tech equities could see modest gains.

adds to overall optimism for the growing space services market.

Counterpoint

High valuation multiples and cash burn could limit upside despite new contracts.

Key entities

  • Rocket Lab

    U.S. listed launch services provider (ticker RKLB).

  • Synspective

    Customer signing the 20‑mission contract.

  • Iridium Communications

    Satellite communications firm being acquired.

Related articles

$RKLBMedAI 8/10

Rocket Lab Challenges NASA’s $700M Mars Orbiter Award to Blue Origin While Scaling Vertical Integration via $8B Iridium Acquisition – SatNews

Rocket Lab USA challenged NASA's $700M Mars orbiter contract to Blue Origin, while acquiring Iridium Communications for $8B. The GAO is reviewing the protest, with a decision expected by mid-December 2026. Rocket Lab aims to vertically integrate its satellite network operations, targeting lower costs and new markets.

$RKLBHighAI 9/10

SpaceX Comfortably Wins on Scale. Here’s How Rocket Lab Still Competes.

Iridium shareholders approved Rocket Lab's $8B acquisition, with 99.6% voting in favor. Rocket Lab (RKLB) will operate a large satellite network. SpaceX (SPCX) grew Starlink subscribers to 12M, with Connectivity revenue up 66% to $4.29B. Rocket Lab competes by offering satellite services to other companies, with lower costs and faster deployment. SpaceX focuses on its own network and cheaper launches with Starship.